• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

469.27 -1.04 (-0.22%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,165,162
Open 469.83
Bid (Size) 463.05 (40)
Ask (Size) 485.00 (40)
Prev. Close 470.31
Today's Range 463.00 - 472.24
52wk Range 362.50 - 519.68
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows ↗
Today 12:32 EST
Via MarketBeat
News headline image
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q4 Earnings Call
Today 0:37 EST
Vertex Pharmaceuticals delivered fourth quarter results that outpaced Wall Street's revenue expectations, driven by continued expansion in cystic fibrosis therapies and early contributions from... 
Via StockStory
Topics Earnings

Performance

YTD
+3.8%
+3.8%
1 Month
+6.2%
+6.2%
3 Month
+11.5%
+11.5%
6 Month
+19.0%
+19.0%
1 Year
+1.5%
+1.5%

More News

Read More
News headline image
Vertex: The Quiet Biotech Compounder I'd Happily Hold Through Any Market Crash ↗
February 18, 2026
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Posts Mixed Q4 2025 Results, Provides 2026 Guidance ↗
February 12, 2026
Via Chartmill
News headline image
Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3
February 17, 2026
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline
February 17, 2026
Via Finterra
Topics Economy Intellectual Property
News headline image
Sanofi Tightens Grip on Ocular Therapeutix with Revised Bid as Pivotal SOL-1 Trial Results Loom
February 16, 2026
Via MarketMinute
News headline image
Moderna, Vertex Pharmaceuticals, Integra LifeSciences, Baxter, and Molina Healthcare Shares Are Soaring, What You Need To Know
February 13, 2026
Via StockStory
Topics Economy
News headline image
The Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026 ↗
February 13, 2026
Via The Motley Fool
Top S&P500 movers in Friday's session ↗
February 13, 2026
Via Chartmill
News headline image
Why CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss) ↗
February 13, 2026
Via The Motley Fool
Friday's session: top gainers and losers in the S&P500 index ↗
February 13, 2026
Via Chartmill
News headline image
Gilead Sciences and the 2026 Biotech Resurgence: A Leader in the Great Rotation
February 13, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Government
News headline image
VRTX Q4 Deep Dive: Diversification Beyond Cystic Fibrosis Sets Stage for Next Growth Phase
February 13, 2026
Via StockStory
News headline image
Vertex (VRTX) Q4 2025 Earnings Call Transcript ↗
February 12, 2026
Via The Motley Fool
Topics Earnings
News headline image
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue
February 12, 2026
Via StockStory
News headline image
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect
February 10, 2026
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell ↗
February 10, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Should You Buy Vertex Before Feb. 12? ↗
February 10, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Provident Dumps 490,000 MapleBear Shares Worth $18 Million ↗
February 09, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Should You Buy Vertex Pharmaceuticals Before Feb. 12? ↗
February 09, 2026
Via The Motley Fool
News headline image
The Bond Market Is Flashing a Clear Warning About the Fed: 3 Stocks to Buy ↗
February 08, 2026
Via The Motley Fool
Topics Bonds Economy Government
News headline image
2 Top Healthcare Stocks to Buy in February ↗
February 07, 2026
Via The Motley Fool
Topics World Trade
News headline image
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
February 06, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 469.27
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 02/19/26 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 121.74B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 122B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap